[FG] Hartmann Karin

Roth, M.S. et al. (2024) ‘Characterization of the Gut and Skin Microbiome over Time in Young Children with IgE-Mediated Food Allergy’, Nutrients, 16(22), p. 3942. Available at: https://doi.org/10.3390/nu16223942.

Valent, P. et al. (2024) ‘Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM’, The Journal of Allergy and Clinical Immunology: In Practice [Preprint]. Available at: https://doi.org/10.1016/j.jaip.2024.08.044.

Pascal, Mariona et al. (2024) ‘Granulocytes and mast cells in AllergoOncology—Bridging allergy to cancer: An EAACI position paper’, Allergy [Preprint]. Available at: https://doi.org/10.1111/all.16246.

Schmid, Alicia et al. (2024) ‘Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM’, Blood Advances, 8(11), pp. 2890–2900. Available at: https://doi.org/10.1182/bloodadvances.2024012756.

Baldrich, Adrian et al. (2024) ‘Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency’, Journal of Clinical Immunology, 44(3). Available at: https://doi.org/10.1007/s10875-024-01667-z.

Worm, Margitta et al. (2024) ‘Occupational anaphylaxis—Data from the anaphylaxis registry’, Allergy: European Journal of Allergy and Clinical Immunology, 79(3), pp. 702–710. Available at: https://doi.org/10.1111/all.15974.

Baldrich, Adrian et al. (2024) ‘Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency’, Journal of Clinical Immunology, 44. Available at: https://doi.org/10.1007/s10875-024-01667-z.

Burgener-Gasser, Anne-Valérie et al. (2024) ‘Assessing the rationale of prescribing carbapenems among hospitalized patients with documented penicillin allergy: Implications for stewardship’, Antimicrobial Stewardship and Healthcare Epidemiology, 4. Available at: https://doi.org/10.1017/ash.2024.5.

Curatolo, R. et al. (2024) ‘Delayed-type hypersensitivity reaction to oral intake of trometamol’, Contact Dermatitis [Preprint]. Available at: https://doi.org/10.1111/cod.14585.

Greiner, Georg et al. (2024) ‘Tumor necrosis factor α promotes clonal dominance of KIT D816V⁺ cells in mastocytosis: role of survivin and impact on prognosis’, Blood, 143, pp. 1006–1017. Available at: https://doi.org/10.1182/blood.2023020515.

Höfer, V. et al. (2024) ‘Fatal and Near-Fatal Anaphylaxis: Data From the European Anaphylaxis Registry and National Health Statistics’, Journal of Allergy and Clinical Immunology: In Practice, 12(1), pp. 96–105.e8. Available at: https://doi.org/10.1016/j.jaip.2023.09.044.

Niedoszytko, M. et al. (2024) ‘Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry’, Allergy: European Journal of Allergy and Clinical Immunology [Preprint]. Available at: https://doi.org/10.1111/all.16132.

Schmid-Grendelmeier, P. et al. (2024) ‘Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies’, Allergy: European Journal of Allergy and Clinical Immunology, 79(1), pp. 174–183. Available at: https://doi.org/10.1111/all.15952.

Zwimpfer, T.A. et al. (2024) ‘Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers’, Cancer Medicine, 13. Available at: https://doi.org/10.1002/cam4.6840.

Bellutti Enders F et al. (2023) ‘Alpha-gal syndrome initially misdiagnosed as chronic spontaneous urticaria in a pediatric patient: a case report and review of the literature’, Journal of Medical Case Reports, 17(1). Available at: https://doi.org/10.1186/s13256-022-03718-8.

Konantz M et al. (2023) ‘Increased TIM-3 and galectin-9 serum levels in patients with advanced systemic mastocytosis.’, The Journal of allergy and clinical immunology, 152(4), pp. 1019–1024. Available at: https://doi.org/10.1016/j.jaci.2023.07.001.

Dölle-Bierke S et al. (2023) ‘Food-Induced Anaphylaxis: Data From the European Anaphylaxis Registry.’, The journal of allergy and clinical immunology. In practice, 11(7), pp. 2069–2079.e7. Available at: https://doi.org/10.1016/j.jaip.2023.03.026.

Hartmann, Karin and Wassmer, Hanna (2023) ‘Childhood mastocytosis Kindliche Mastozytose’, Dermatologie, 74(7). Available at: https://doi.org/10.1007/s00105-023-05174-x.

Limberg MM et al. (2023) ‘Eosinophils, Basophils, and Neutrophils in Bullous Pemphigoid.’, Biomolecules, 13(7). Available at: https://doi.org/10.3390/biom13071019.

Valent P et al. (2023) ‘European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives.’, The journal of allergy and clinical immunology. In practice, 11(6), pp. 1706–1717. Available at: https://doi.org/10.1016/j.jaip.2023.02.021.

Castells, Mariana et al. (2023) ‘Avapritinib versus Placebo in Indolent Systemic Mastocytosis’, NEJM Evidence, 2(6). Available at: https://doi.org/10.1056/evidoa2200339.

Kennedy VE et al. (2023) ‘Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry.’, Blood advances, 7(9), pp. 1713–1724. Available at: https://doi.org/10.1182/bloodadvances.2022008292.

Akin C. et al. (2023) ‘Legends of Allergy and Immunology—Dean D. Metcalfe’, Allergy: European Journal of Allergy and Clinical Immunology, 78(5), pp. 1395–1396. Available at: https://doi.org/10.1111/all.15657.

Konantz M et al. (2023) ‘MRGPRX2: A novel biomarker in mastocytosis?’, Journal of Allergy and Clinical Immunology: In Practice, 11(2), pp. 669–671. Available at: https://doi.org/10.1016/j.jaip.2022.10.053.

Lübke J et al. (2023) ‘Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis.’, The journal of allergy and clinical immunology. In practice, 11(2), pp. 581–590.e5. Available at: https://doi.org/10.1016/j.jaip.2022.10.051.

Scherer Hofmeier K. and Bircher A.J. (2023) ‘NaOH is not NaCl - Ulcerous Reaction to Sodium Hydroxide Solution in Patch Tests with Ingredients of a Sunscreen Product NaOH ist nicht NaCl - ulzeröse Reaktion auf Natronlauge bei der Epikutantestung der Inhaltsstoffe einer Sonnenschutzcreme’, Aktuelle Dermatologie, 49(1-2), pp. 47–51. Available at: https://doi.org/10.1055/a-1576-6758.

Giannetti M.P. et al. (2023) ‘Outcomes of COVID-19 vaccination in 323 patients with clonal and non-clonal mast cell activation disorders’, Allergy: European Journal of Allergy and Clinical Immunology, 78(1), pp. 301–304. Available at: https://doi.org/10.1111/all.15476.

Hundt, J.E. et al. (2023) ‘A life for autoimmune blistering diseases: in memoriam Detlef Zillikens’, Frontiers in Immunology, 14. Available at: https://doi.org/10.3389/fimmu.2023.1291590.

Schwaab, Juliana, Horny, Hans-Peter and Hartmann, Karin (2023) ‘Diagnosis and treatment of systemic mastocytosis’, Best Practice Onkologie, 18, pp. 524–533. Available at: https://doi.org/10.1007/s11654-023-00531-7.

Valent, P. et al. (2023) ‘The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT’, Journal of Allergy and Clinical Immunology: In Practice, 11, pp. 3010–3020. Available at: https://doi.org/10.1016/j.jaip.2023.08.008.

Schwaab J., Horny H.-P. and Hartmann K. (2023) ‘Diagnosis and treatment of systemic mastocytosis’, Onkologie, 29, pp. 323–328. Available at: https://doi.org/10.1007/s00761-022-01269-7.

Wassmer H. and Hartmann K. (2023) ‘Mastocytosis in children’, Dermatologie [Preprint]. Available at: https://doi.org/10.1007/s00105-023-05168-9.

Wassmer H. and Hartmann K. (2023) ‘Mastocytosis in children’, Monatsschrift fur Kinderheilkunde, 171, pp. 430–438. Available at: https://doi.org/10.1007/s00112-023-01757-z.

Kirsch M et al. (2022) ‘Presence of neoplastic mast cells in ascites in advanced systemic mastocytosis.’, The journal of allergy and clinical immunology. In practice, 10(11), pp. 3035–3038.e1. Available at: https://doi.org/10.1016/j.jaip.2022.07.014.

Roth MS et al. (2022) ‘Safe administration of subsequent mRNA COVID-19 vaccine doses following a possible allergic reaction to the first dose’, Journal of the European Academy of Dermatology and Venereology, 36(11), pp. e880–e883. Available at: https://doi.org/10.1111/jdv.18387.

Bergmann C et al. (2022) ‘AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper.’, Allergy, 77(9), pp. 2594–2617. Available at: https://doi.org/10.1111/all.15255.

Barbaud A. et al. (2022) ‘Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper’, Allergy: European Journal of Allergy and Clinical Immunology, 77(8), pp. 2292–2312. Available at: https://doi.org/10.1111/all.15241.

Gotlib J et al. (2022) ‘Proposed European Competence Network on Mastocytosis-American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis.’, The journal of allergy and clinical immunology. In practice, 10(8), pp. 2025–2038.e1. Available at: https://doi.org/10.1016/j.jaip.2022.05.034.

Hoermann G et al. (2022) ‘Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group.’, The journal of allergy and clinical immunology. In practice, 10(8), pp. 1953–1963. Available at: https://doi.org/10.1016/j.jaip.2022.03.001.

Jennings SV et al. (2022) ‘Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond.’, The journal of allergy and clinical immunology. In practice, 10(8), pp. 2039–2051. Available at: https://doi.org/10.1016/j.jaip.2022.06.018.

Pyatilova P et al. (2022) ‘Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium.’, The journal of allergy and clinical immunology. In practice, 10(8), pp. 2015–2024. Available at: https://doi.org/10.1016/j.jaip.2022.05.037.

Sotlar K et al. (2022) ‘Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group.’, The journal of allergy and clinical immunology. In practice, 10(8), pp. 1986–1998.e2. Available at: https://doi.org/10.1016/j.jaip.2022.05.036.

Valent P et al. (2022) ‘Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium.’, The journal of allergy and clinical immunology. In practice, 10(8), pp. 1941–1950. Available at: https://doi.org/10.1016/j.jaip.2022.05.007.

Valent P et al. (2022) ‘Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice.’, The journal of allergy and clinical immunology. In practice, 10(8), pp. 1999–2012.e6. Available at: https://doi.org/10.1016/j.jaip.2022.03.007.

Bircher A.J. et al. (2022) ‘Skin Prick Test as a Provocation Test-Severe Anaphylactic Reaction to Skin Tests with Ceftriaxone in Two Occupationally Exposed Workers Pricktest als Provokation-schwere anaphylaktische Reaktion auf Hauttests mit Ceftriaxon bei beruflicher Exposition’, Aktuelle Dermatologie, 48(7), pp. 301–305. Available at: https://doi.org/10.1055/a-1539-1958.

Arock M et al. (2022) ‘Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022.’, The Journal of allergy and clinical immunology, 149(6), pp. 1855–1865. Available at: https://doi.org/10.1016/j.jaci.2022.04.004.

Redhu D et al. (2022) ‘Mast cells instruct keratinocytes to produce thymic stromal lymphopoietin: Relevance of the tryptase/protease-activated receptor 2 axis.’, The Journal of allergy and clinical immunology, 149(6), pp. 2053–2061.e6. Available at: https://doi.org/10.1016/j.jaci.2022.01.029.

Valent P et al. (2022) ‘Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?’, The Journal of allergy and clinical immunology, 149(6), pp. 1866–1874. Available at: https://doi.org/10.1016/j.jaci.2022.04.003.

Nsiah-Dosu S et al. (2022) ‘Mast cell-deficient mice Mcpt5Cre/Dicer (fl/fl) redefine the role of mast cells in experimental bullous pemphigoid.’, Skin health and disease, 2(1), p. e70. Available at: https://doi.org/10.1002/ski2.70.

Zanotti R et al. (2022) ‘Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis.’, Leukemia, 36(2), pp. 516–524. Available at: https://doi.org/10.1038/s41375-021-01406-y.

Cajacob, Lucian, Chantraine, Sibylla and Hartmann, Karin (2022) ‘Allergic Contact Stomatitis’. Springer International Publishing, pp. 423–426. Available at: https://doi.org/10.1007/978-3-030-82804-2_39.

Valent P et al. (2022) ‘Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022.’, International archives of allergy and immunology, 183(7), pp. 693–705. Available at: https://doi.org/10.1159/000524532.

Bircher A.J. et al. (2022) ‘Small Cause - Big Effect: Delayed-type Skin Tests with Drugs as Trigger of Disseminated Relapse Exanthems’, Aktuelle Dermatologie, 48, pp. 260–266. Available at: https://doi.org/10.1055/a-1539-2221.

Bircher A.J. and Scherer Hofmeier K. (2022) ‘Intradermal Skin Test-Induced Tattoos from Color-Containing Drugs’, Aktuelle Dermatologie [Preprint]. Available at: https://doi.org/10.1055/a-1515-1517.

Scherer Hofmeier K. and Bircher A.J. (2022) ‘Isolated Tongue Swelling after Penicillin and Negative Allergy Workup - All Done and Dusted?’, Aktuelle Dermatologie, 48, pp. 255–259. Available at: https://doi.org/10.1055/a-1543-0663.

Kraft M et al. (2021) ‘Anaphylaxis to vaccination and polyethylene glycol: a perspective from the European Anaphylaxis Registry.’, 35(10). Available at: https://doi.org/10.1111/jdv.17327.

Kraft M et al. (2021) ‘Wheat Anaphylaxis in Adults Differs from Reactions to Other Types of Food.’, The journal of allergy and clinical immunology. In practice, 9(7), pp. 2844–2852.e5. Available at: https://doi.org/10.1016/j.jaip.2021.03.037.

Becker S et al. (2021) ‘A meta-analysis on allergen-specific immunotherapy using MCT(®) (MicroCrystalline Tyrosine)-adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis.’, Clinical and translational allergy, 11(4), p. e12037. Available at: https://doi.org/10.1002/clt2.12037.

Torres MJ et al. (2021) ‘Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity.’, Allergy, 76(5), pp. 1325–1339. Available at: https://doi.org/10.1111/all.14656.

Loman L et al. (2021) ‘European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitis.’, Contact dermatitis, 85(2), pp. 186–97. Available at: https://doi.org/10.1111/cod.13833.

Golebski K et al. (2021) ‘Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response.’, Immunity, 54(2), pp. 291–307.e7. Available at: https://doi.org/10.1016/j.immuni.2020.12.013.

Francuzik W et al. (2021) ‘Phenotype and risk factors of venom-induced anaphylaxis: A case-control study of the European Anaphylaxis Registry.’, The Journal of allergy and clinical immunology, 147(2), pp. 653–662.e9. Available at: https://doi.org/10.1016/j.jaci.2020.06.008.

Uter W et al. (2021) ‘Patch test results with the European baseline series and additions thereof in the ESSCA network, 2015-2018’, Contact Dermatitis, 84(2), pp. 109–120. Available at: https://doi.org/10.1111/cod.13704.

Aberer, Elisabeth et al. (2021) ‘Clinical impact of skin lesions in mastocytosis: a multicenter study of the European Competence Network on Mastocytosis (ECNM)’, The Journal of Investigative Dermatology, 141(7), pp. 1719–1727. Available at: https://doi.org/10.1016/j.jid.2020.12.030.

Bonadonna, Patrizia et al. (2021) ‘COVID-19 vaccination in mastocytosis: recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)’, The Journal of Allergy and Clinical Immunology. In Practice, 9(6), pp. 2139–2144. Available at: https://doi.org/10.1016/j.jaip.2021.03.041.

Bürgler, A. et al. (2021) ‘Rationale and design of a panel study investigating six health effects of airborne pollen: the EPOCHAL study’, Frontiers in Public Health, 9, p. 689248. Available at: https://doi.org/10.3389/fpubh.2021.689248.

Francuzik W et al. (2021) ‘Anaphylaxis in middle-aged patients.’, Allergologie select, 5, pp. 133–139. Available at: https://doi.org/10.5414/alx02216e.

Fuchs, David et al. (2021) ‘Scoring the risk of having systemic mastocytosis in adult patients with mastocytosis in the skin’, The Journal of Allergy and Clinical Immunology: In Practice, 9(4), pp. 1705–1712.e4. Available at: https://doi.org/10.1016/j.jaip.2020.12.022.

Giannetti, Matthew P. et al. (2021) ‘COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms’, The Journal of Allergy and Clinical Immunology: In Practice, 9(5), pp. 2083–2086. Available at: https://doi.org/10.1016/j.jaip.2021.02.023.

Gotlib, Jason et al. (2021) ‘Practical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurin’, Expert Opinion on Biological Therapy, 21(4), pp. 487–498. Available at: https://doi.org/10.1080/14712598.2021.1837109.

Gülen, Theo et al. (2021) ‘Selecting the right criteria and proper classification to diagnose mast cell activation syndromes: a critical review’, The Journal of Allergy and Clinical Immunology. In Practice, 9(11), pp. 3918–3928. Available at: https://doi.org/10.1016/j.jaip.2021.06.011.

Hirsiger, J. R. et al. (2021) ‘Anaphylaxis to goat’s and sheep’s milk in an adult tolerant to cow milk: A sensitization profile study’, Journal of Investigational Allergology & Clinical Immunology, 32(2), pp. 154–156. Available at: https://doi.org/10.18176/jiaci.0721.

Jamiolkowski, Dagmar et al. (2021) ‘Structured diagnostic assessment of hand eczema in cleaning workers’, Journal der Deutschen Dermatologischen Gesellschaft, 19(5), pp. 672–676. Available at: https://doi.org/10.1111/ddg.14452.

Jamiolkowski, Dagmar et al. (2021) ‘Strukturierte diagnostische Abklärung eines Handekzems bei Reinigungsfachkräften’, JDDG - Journal of the German Society of Dermatology, 19(5), pp. 672–678. Available at: https://doi.org/10.1111/ddg.14452_g.

Klimek, Ludger et al. (2021) ‘Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI’, Allergo Journal International, 30(3), pp. 79–95. Available at: https://doi.org/10.1007/s40629-021-00165-7.

Klimek, Ludger et al. (2021) ‘Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA)’, Allergo Journal, 30(2), pp. 51–55. Available at: https://doi.org/10.1007/s40629-020-00160-4.

Kluin-Nelemans, Hanneke C. et al. (2021) ‘Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis’, Theranostics, 11(1), pp. 292–303. Available at: https://doi.org/10.7150/thno.51872.

Lange, Magdalena et al. (2021) ‘Molecular background, clinical features and management of pediatric mastocytosis: Status 2021’, International journal of molecular sciences, 22(5), p. 2586. Available at: https://doi.org/10.3390/ijms22052586.

Peters, Franziska et al. (2021) ‘Detection of the Germline KIT S476I Mutation in a Kindred with Familial Mastocytosis associated with Gastrointestinal Stromal Tumors’, The Journal of Allergy and Clinical Immunology. In Practice, 9(5), pp. 2123–2125.e1. Available at: https://doi.org/10.1016/j.jaip.2020.12.049.

Steveling-Klein, Esther Helen et al. (2021) ‘Management of hypersensitivity reactions to nondextran iron products: new insights into predisposing risk factors’, The Journal of Allergy and Clinical Immunology: In Practice, 9(6), pp. 2406–2414.e2. Available at: https://doi.org/10.1016/j.jaip.2021.01.009.

Thomas, Zita-Rose Manjaly et al. (2021) ‘Contact dermatitis to hair cosmetics: current diagnostic recommendations’, Journal der Deutschen Dermatologischen Gesellschaft (DDG), 19(12), pp. 1729–1734. Available at: https://doi.org/10.1111/ddg.14544.

Thomas, Zita-Rose Manjaly et al. (2021) ‘Kontaktekzem auf Haarkosmetikprodukte: Aktuelle Empfehlungen zur Diagnostik’, JDDG - Journal of the German Society of Dermatology, 19(12), pp. 1729–1735. Available at: https://doi.org/10.1111/ddg.14544_g.

Trachsel, Tina et al. (2021) ‘Cannabisallergie’, Swiss Medical Forum, 21(25-26), pp. 449–451. Available at: https://doi.org/10.4414/smf.2021.08677.

Valent, Peter et al. (2021) ‘Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal’, HemaSphere, 5(11), p. e646. Available at: https://doi.org/10.1097/hs9.0000000000000646.

Francuzik W. et al. (2021) ‘Anaphylaxis in middle-aged patients’, Allergologie, 44, pp. 297–305. Available at: https://doi.org/10.5414/alx02216.

Kraft M et al. (2020) ‘Risk Factors and Characteristics of Biphasic Anaphylaxis.’, The journal of allergy and clinical immunology. In practice, 8(10), pp. 3388–3395.e6. Available at: https://doi.org/10.1016/j.jaip.2020.07.036.

Terrani I, Scherer Hofmeier K and Bircher AJ (2020) ‘Indium and iridium: Two rare metals with a high rate of contact sensitization.’, Contact dermatitis, 83(2), pp. 94–98. Available at: https://doi.org/10.1111/cod.13549.

Kraft M. et al. (2020) ‘Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry’, Allergy: European Journal of Allergy and Clinical Immunology, 75(4), pp. 901–910. Available at: https://doi.org/10.1111/all.14069.

Ernst, N. et al. (2020) ‘Expression of PD-1 and Tim-3 is increased in skin of patients with bullous pemphigoid and pemphigus vulgaris’, Journal of the European Academy of Dermatology and Venereology, 35(2), pp. 486–492. Available at: https://doi.org/10.1111/jdv.16780.

Ferastraoaru, D. et al. (2020) ‘AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer - a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)’, Clinical and Translational Allergy, 10(1), p. 32. Available at: https://doi.org/10.1186/s13601-020-00335-w.

Goldust, Mohamad et al. (2020) ‘Utility and risk of dermatologic medications during the COVID-19 pandemic’, Dermatologic Therapy, p. e13833. Available at: https://doi.org/10.1111/dth.13833.

Hartmann, Karin et al. (2020) ‘Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis’, Journal of Allergy and Clinical Immunology, 146(2), pp. 356–366.e4. Available at: https://doi.org/10.1016/j.jaci.2020.03.044.

Jamiolkowski, Dagmar et al. (2020) ‘Multilocular bullous fixed drug eruption elicited by paracetamol and migraine attacks, but not by paracetamol alone’, Contact Dermatitis, 83(3), pp. 233–234. Available at: https://doi.org/10.1111/cod.13567.

Kluin-Nelemans, Hanneke C. et al. (2020) ‘Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry’, Leukemia, 34(4), pp. 1090–1101. Available at: https://doi.org/10.1038/s41375-019-0632-4.

Landolina, Nadine et al. (2020) ‘Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells’, Pharmacological Research, 158, p. 104682. Available at: https://doi.org/10.1016/j.phrs.2020.104682.

Manjaly Thomas, Zita-Rose et al. (2020) ‘Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities’, Journal Of Allergy And Clinical Immunology, 146(4), pp. 786–789. Available at: https://doi.org/10.1016/j.jaci.2020.07.008.

Maurer, Marcus et al. (2020) ‘Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020’, International Archives of Allergy and Immunology, 181(5), pp. 321–333. Available at: https://doi.org/10.1159/000507218.

Mueller, Simon M. et al. (2020) ‘Fiction, Falsehoods, and Few Facts: Cross-Sectional Study on the Content-Related Quality of Atopic Eczema-Related Videos on YouTube’, Journal of Medical Internet Research, 22(4), p. e15599. Available at: https://doi.org/10.2196/15599.

Neumann, Kristina et al. (2020) ‘Natatorial mishap: Skin lesions caused by jellyfish stings’, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 18(5), pp. 473–475. Available at: https://doi.org/10.1111/ddg.14088.

Rongisch, Robert et al. (2020) ‘Travel-associated infectious skin diseases’, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology, 18(7), pp. 730–733. Available at: https://doi.org/10.1111/ddg.14094.